Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:omecamtiv_mecarbil
|
| gptkbp:ATCCode |
C01EB
|
| gptkbp:CASNumber |
873697-71-3
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:Amgen
gptkb:Cytokinetics |
| gptkbp:firstReported |
2006
|
| gptkbp:hasMolecularFormula |
C25H30N6O3S
|
| https://www.w3.org/2000/01/rdf-schema#label |
CK-1827452
|
| gptkbp:intendedUse |
treatment of heart failure
|
| gptkbp:mechanismOfAction |
cardiac myosin activator
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL2103888
11561637 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:status |
investigational
|
| gptkbp:target |
cardiac myosin
|
| gptkbp:therapeuticArea |
cardiology
|
| gptkbp:UNII |
6Z5B6HVF6O
|
| gptkbp:bfsParent |
gptkb:omecamtiv_mecarbil
|
| gptkbp:bfsLayer |
7
|